AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INCYTE CORP Director's Dealing 2022

Jan 21, 2022

30371_dirs_2022-01-21_62151823-7854-44c1-9c5c-619c376a83ec.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INCYTE CORP (INCY)
CIK: 0000879169
Period of Report: 2022-01-19

Reporting Person: Dhanak Dashyant (EVP & Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-19	Employee Stock Option (right to buy)	$74.78	A	15054	Acquired	2032-01-18	Common Stock (15054)	Direct

Footnotes

F1: Beginning January 19, 2022, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2022 and the remainder vesting monthly over three years.